1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA AAAS CTRPv2 pan-cancer AAC -0.13 0.0008
mRNA MT1H CTRPv2 pan-cancer AAC 0.12 0.0008
mRNA NMT2 CTRPv2 pan-cancer AAC -0.12 0.0008
mRNA DCK CTRPv2 pan-cancer AAC -0.14 0.0008
mRNA VILL CTRPv2 pan-cancer AAC 0.13 0.0008
mRNA RFC4 CTRPv2 pan-cancer AAC -0.12 0.0008
mRNA KDF1 CTRPv2 pan-cancer AAC 0.15 0.0008
mRNA MYBL2 CTRPv2 pan-cancer AAC -0.13 0.0008
mRNA ZCRB1 CTRPv2 pan-cancer AAC -0.12 0.0008
mRNA DDX50 CTRPv2 pan-cancer AAC -0.12 0.0008
Download CSV